Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 6
Laboratoires Pierre Fabre SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7
Laboratoires Pierre Fabre SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 8
Laboratoires Pierre Fabre SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9
Laboratoires Pierre Fabre SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 10
Laboratoires Pierre Fabre SA, Medical Devices Deals, 2012 to YTD 2018 12
Laboratoires Pierre Fabre SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 13
Laboratoires Pierre Fabre SA, Pharmaceuticals & Healthcare, Deal Details 17
Asset Purchase 17
Pierre Fabre Pharma Acquires Promising Assets from Igenica Biotherapeutics 17
Pierre Fabre Acquires Desogestrel from Helm Medical 18
Partnerships 19
Pierre Fabre Enters into Distribution Agreement with Medinova 19
Crown Bioscience Enters into Partnership Agreement with Pierre Fabre Research Institute 20
Pierre Fabre Expands Agreement with Roche for W0101 21
Pierre Fabre Enters into Agreement with MEME Cosmetics 22
Institut Curie Enters into Agreement with Pierre Fabre 23
Laboratoires Pierre Fabre Enters into Distribution Agreement with BMG Pharma 24
Fine Foods & Pharma Enters into Distribution Agreement with Pierre Fabre 25
Laboratoires Pierre Fabre Enters into Research Agreement with H-Immune 26
Laboratoires Pierre Fabre Enters into Licensing Agreement with PIQUR Therapeutics 27
Pierre Fabre Pharma Enters into Partnership with Yale School of Medicine 28
Evotec Partners with Pierre Fabre Labs 29
Pierre Fabre Partners with VibioSphen 30
Pierre Fabre Medicament Enters into Agreement with Pfizer for Toviaz 31
Pierre Fabre Enters into Co-Development Agreement with Array BioPharma 32
Cellectar Biosciences Extends Agreement with Pierre Fabre Lab 33
Pierre Fabre Medicament Partners with Inserm Transfert 34
Pierre Fabre Medicament Enters into Agreement with Ecole Polytechnique Federale de Lausanne 35
Pierre Fabre Partners with Biomax Informatics 36
AbCheck Expands Research Agreement with Pierre Fabre Pharma 37
Pierre Fabre Enters into Co-Promotion Agreement with Laboratoires Thea 38
Pierre Fabre Enters into Distribution Agreement with Laboratorios Vinas for Molusderm 39
AbCheck Enters Into Research Agreement With Pierre Fabre 40
Pierre Fabre Enters into Co-Promotion Agreement with Bristol-Myers Squibb for Orencia 41
Redx Pharma Enters into Research Agreement with Pierre Fabre Labs 42
Laboratoires Pierre Fabre Enters into Partnership with UPMC and CNRS 43
Pierre Fabre Enters into Agreement with Roche for NeoRecormon 44
Pierre Fabre Enters into Agreement with Geiser Pharma 45
Pierre Fabre Medicament Enters Into Co-Promotion Agreement With AstraZeneca For Zoladex 46
Merz Enters Into Co-Marketing Agreement With Pierre Fabre For Injectable Glytone 47
ADVENTRX Pharma and Pierre Fabre Medicament Enter into Agreement for ANX-188 48
Licensing Agreements 49
Boston Pharma Enters into Licensing Agreement Laboratoires Pierre 49
Substipharm Enters into Licensing Agreement with Pierre Fabre 50
Pierre Fabre Enters into Licensing Agreement with Hill Derma 51
Fertin Pharma Enters into License and Supply Agreement with Pierre Fabre 52
Pierre Fabre Labs Enters into Licensing Agreement with Sigma-Tau 53
Darya-Varia Enters into Licensing Agreement with Pierre Fabre 54
Pierre Fabre Enters into Licensing Agreement with Hermes Pharma 55
Pierre Fabre Enters into Licensing Agreement with Alpex Pharma 56
Aurigene Discovery Technologies Enters Into Licensing Agreement With Pierre Fabre For AUNP-12 57
Pierre Fabre Enters into Licensing Agreement with Disphar International for Naproxen 58
Pierre Fabre Enters into Licensing Agreement with Laboratoires Juvise Pharma for Etumina 59
Pierre Fabre Enters into Licensing Agreement with Lonza 60
Pierre Fabre Enters into Licensing Agreement with Lonza 61
Pierre Fabre Extends Licensing Agreement with Catalent France for Curacne 62
Fertin Pharma Enters into License, Distribution and Supply Agreement with Pierre Fabre 63
Pierre Fabre Enters into Licensing Agreement with Medis 64
Pierre Fabre Pharma Enters into Licensing Agreement with Addex Therapeutics 65
Pierre Fabre Enters into Licensing Agreement with PLEURAN 66
Pierre Fabre Enters into Licensing Agreement with Laboratoire Top Pharm 67
Pierre Fabre Enters into Licensing Agreement with Bioiberica for Tendoactive 68
Neurolixis Enters Into Licensing Agreement With Pierre Fabre Medicament 69
Pierre Fabre Enters Into Licensing Agreement With Maruho For Infant Hemangiomas Treatment 71
Pierre Fabre Enters into Licensing Agreement with Losan Pharma 72
Equity Offering 73
Pierre Fabre Invests in MEME Cosmetics 73
TargeOn Raises Funds through Private Placement of Shares 74
Asset Transactions 75
Amatsigroup Acquires R&D Center from Pierre Fabre Labs 75
Acquisition 76
Pierre Fabre Sells 6% Stake In Boiron For US$42 Million 76
Laboratoires Pierre Fabre SA – Key Competitors 77
Laboratoires Pierre Fabre SA – Key Employees 78
Laboratoires Pierre Fabre SA – Locations And Subsidiaries 79
Head Office 79
Other Locations & Subsidiaries 79
Affiliate 82
Recent Developments 83
Corporate Communications 83
May 04, 2018: Pierre Fabre Appoints Eric Ducournau As New Chief Executive Officer 83
Other Significant Developments 84
Jun 15, 2018: Feelcaps, to promote physical activity among cancer patients 84
Oct 10, 2017: Cellectar Biosciences and Pierre Fabre Extend Collaboration for Development of New Phospholipid Drug Conjugates 85
Appendix 86
Methodology 86
About GlobalData 86
Contact Us 86
Disclaimer 86
Laboratoires Pierre Fabre SA, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Laboratoires Pierre Fabre SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7
Laboratoires Pierre Fabre SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 8
Laboratoires Pierre Fabre SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9
Laboratoires Pierre Fabre SA, Deals By Therapy Area, 2012 to YTD 2018 10
Laboratoires Pierre Fabre SA, Medical Devices Deals, 2012 to YTD 2018 12
Laboratoires Pierre Fabre SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 13
Pierre Fabre Pharma Acquires Promising Assets from Igenica Biotherapeutics 17
Pierre Fabre Acquires Desogestrel from Helm Medical 18
Pierre Fabre Enters into Distribution Agreement with Medinova 19
Crown Bioscience Enters into Partnership Agreement with Pierre Fabre Research Institute 20
Pierre Fabre Expands Agreement with Roche for W0101 21
Pierre Fabre Enters into Agreement with MEME Cosmetics 22
Institut Curie Enters into Agreement with Pierre Fabre 23
Laboratoires Pierre Fabre Enters into Distribution Agreement with BMG Pharma 24
Fine Foods & Pharma Enters into Distribution Agreement with Pierre Fabre 25
Laboratoires Pierre Fabre Enters into Research Agreement with H-Immune 26
Laboratoires Pierre Fabre Enters into Licensing Agreement with PIQUR Therapeutics 27
Pierre Fabre Pharma Enters into Partnership with Yale School of Medicine 28
Evotec Partners with Pierre Fabre Labs 29
Pierre Fabre Partners with VibioSphen 30
Pierre Fabre Medicament Enters into Agreement with Pfizer for Toviaz 31
Pierre Fabre Enters into Co-Development Agreement with Array BioPharma 32
Cellectar Biosciences Extends Agreement with Pierre Fabre Lab 33
Pierre Fabre Medicament Partners with Inserm Transfert 34
Pierre Fabre Medicament Enters into Agreement with Ecole Polytechnique Federale de Lausanne 35
Pierre Fabre Partners with Biomax Informatics 36
AbCheck Expands Research Agreement with Pierre Fabre Pharma 37
Pierre Fabre Enters into Co-Promotion Agreement with Laboratoires Thea 38
Pierre Fabre Enters into Distribution Agreement with Laboratorios Vinas for Molusderm 39
AbCheck Enters Into Research Agreement With Pierre Fabre 40
Pierre Fabre Enters into Co-Promotion Agreement with Bristol-Myers Squibb for Orencia 41
Redx Pharma Enters into Research Agreement with Pierre Fabre Labs 42
Laboratoires Pierre Fabre Enters into Partnership with UPMC and CNRS 43
Pierre Fabre Enters into Agreement with Roche for NeoRecormon 44
Pierre Fabre Enters into Agreement with Geiser Pharma 45
Pierre Fabre Medicament Enters Into Co-Promotion Agreement With AstraZeneca For Zoladex 46
Merz Enters Into Co-Marketing Agreement With Pierre Fabre For Injectable Glytone 47
ADVENTRX Pharma and Pierre Fabre Medicament Enter into Agreement for ANX-188 48
Boston Pharma Enters into Licensing Agreement Laboratoires Pierre 49
Substipharm Enters into Licensing Agreement with Pierre Fabre 50
Pierre Fabre Enters into Licensing Agreement with Hill Derma 51
Fertin Pharma Enters into License and Supply Agreement with Pierre Fabre 52
Pierre Fabre Labs Enters into Licensing Agreement with Sigma-Tau 53
Darya-Varia Enters into Licensing Agreement with Pierre Fabre 54
Pierre Fabre Enters into Licensing Agreement with Hermes Pharma 55
Pierre Fabre Enters into Licensing Agreement with Alpex Pharma 56
Aurigene Discovery Technologies Enters Into Licensing Agreement With Pierre Fabre For AUNP-12 57
Pierre Fabre Enters into Licensing Agreement with Disphar International for Naproxen 58
Pierre Fabre Enters into Licensing Agreement with Laboratoires Juvise Pharma for Etumina 59
Pierre Fabre Enters into Licensing Agreement with Lonza 60
Pierre Fabre Enters into Licensing Agreement with Lonza 61
Pierre Fabre Extends Licensing Agreement with Catalent France for Curacne 62
Fertin Pharma Enters into License, Distribution and Supply Agreement with Pierre Fabre 63
Pierre Fabre Enters into Licensing Agreement with Medis 64
Pierre Fabre Pharma Enters into Licensing Agreement with Addex Therapeutics 65
Pierre Fabre Enters into Licensing Agreement with PLEURAN 66
Pierre Fabre Enters into Licensing Agreement with Laboratoire Top Pharm 67
Pierre Fabre Enters into Licensing Agreement with Bioiberica for Tendoactive 68
Neurolixis Enters Into Licensing Agreement With Pierre Fabre Medicament 69
Pierre Fabre Enters Into Licensing Agreement With Maruho For Infant Hemangiomas Treatment 71
Pierre Fabre Enters into Licensing Agreement with Losan Pharma 72
Pierre Fabre Invests in MEME Cosmetics 73
TargeOn Raises Funds through Private Placement of Shares 74
Amatsigroup Acquires R&D Center from Pierre Fabre Labs 75
Pierre Fabre Sells 6% Stake In Boiron For US$42 Million 76
Laboratoires Pierre Fabre SA, Key Competitors 77
Laboratoires Pierre Fabre SA, Key Employees 78
Laboratoires Pierre Fabre SA, Other Locations 79
Laboratoires Pierre Fabre SA, Subsidiaries 80
Laboratoires Pierre Fabre SA, Affiliate 82
List of Figures
Laboratoires Pierre Fabre SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Laboratoires Pierre Fabre SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Laboratoires Pierre Fabre SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Laboratoires Pierre Fabre SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Laboratoires Pierre Fabre SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7
Laboratoires Pierre Fabre SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 8
Laboratoires Pierre Fabre SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9
Laboratoires Pierre Fabre SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 10
Laboratoires Pierre Fabre SA, Medical Devices Deals, 2012 to YTD 2018 12